People In Brief
This article was originally published in The Gray Sheet
Quest IVD focus: Quest Diagnostics hired Glen Freiberg Sept. 29 to run quality and regulatory functions for its three businesses that develop in vitro diagnostic test kits - Focus Diagnostics, Enterix and HemoCue. The former Gen-Probe and SpectraScience regulatory executive will take the title of executive director for IVD Quality and Compliance. Quest wants Freiberg to better align regulatory practices across the three units, which have a distinct focus from Quest's broader clinical lab services business
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.